UNSPSC 85632314: Revision of autologous tissue substitute in right breast, via natural or artificial opening endoscopic

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of autologous tissue substitute in right breast, via natural or artificial opening endoscopic. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0HWT87Z

UNSPSC 85632314 Revision of autologous tissue substitute in right breast via natural or artificial opening endoscopic is a Commodity code that shows little relevant recent activity under state and local procurement. The code's nominal scope — a highly specific surgical procedure code from clinical taxonomy — does not align with the state and local contract opportunities currently tagged to it. Recent solicitations posted under this code include independent medical evaluation services for pension disability determinations, surgical procedure carve-out benefits management, occupational medical surveillance, specialty healthcare services for detained youth, pharmacy benefit management, and temporary health professional staffing — none of which involve autologous tissue revision or breast surgery procedures. The mismatch suggests either a classification artifact or mistagging by issuing bodies rather than active procurement demand for the surgical procedure itself.

State and local governments do not appear to be soliciting revision of autologous tissue substitute procedures as a direct procurement line item under this code. Buyers include the City of Phoenix Retirement Office, City of Long Beach, Washington State Department of Transportation, Harris County Juvenile Probation Department, Collier County Board of County Commissioners, and County of Santa Clara Health System — representing municipalities, state agencies, and county health systems — but their work scopes diverge substantially from the code's clinical procedure name. Unless recent activity reflects genuine demand for autologous tissue breast revision surgery services from state or local health systems, this code presents limited pursuit opportunity in the current market.